Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
MARKER THERAPEUTICS, INC. (MRKR) had Stock-Based Compensation of $0.18M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.18M |
|
-- |
|
-- |
|
$4.07M |
|
$-4.07M |
|
$0.89M |
|
$-3.18M |
|
$-3.18M |
|
$-3.18M |
|
$-3.18M |
|
$-3.18M |
|
$-3.18M |
|
$-4.07M |
|
$-4.07M |
|
19.31M |
|
19.31M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$17.43M |
|
-- |
|
-- |
|
$17.43M |
|
$3.64M |
|
-- |
|
-- |
|
$3.64M |
|
$13.80M |
|
$13.80M |
|
$13.80M |
|
16.70M |
|
| Cash Flow Statement Financials | |
$-1.40M |
|
-- |
|
-- |
|
$17.04M |
|
$15.64M |
|
$-1.40M |
|
|
Stock-Based Compensation |
$0.18M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.79 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.05% |
|
-23.05% |
|
-18.24% |
|
-23.05% |
|
$0.83 |
|
$-0.07 |
|
$-0.07 |
|